BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2140509)

  • 21. [P53 and cancers].
    May P; May E
    Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of the retinoblastoma suppressor gene.
    Bookstein R; Lee WH
    Crit Rev Oncog; 1991; 2(3):211-27. PubMed ID: 1888791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular proteins that are targetted by DNA tumor viruses for transformation.
    Dyson N; Buchkovich K; Whyte P; Harlow E
    Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle.
    Tommasino M; Crawford L
    Bioessays; 1995 Jun; 17(6):509-18. PubMed ID: 7575492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutations: gains or losses?
    Michalovitz D; Halevy O; Oren M
    J Cell Biochem; 1991 Jan; 45(1):22-9. PubMed ID: 2005181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The retinoblastoma gene and gene product.
    Weinberg RA
    Cancer Surv; 1992; 12():43-57. PubMed ID: 1638547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour suppressor genes and molecular chaperones.
    Lane DP; Midgley C; Hupp T
    Philos Trans R Soc Lond B Biol Sci; 1993 Mar; 339(1289):369-72; discussion 372-3. PubMed ID: 8493291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the cell cycle by viral oncoproteins.
    Vousden KH
    Semin Cancer Biol; 1995 Apr; 6(2):109-16. PubMed ID: 7647307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53: an overview of over two decades of study.
    Cheah PL; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an Rb mutation in the mouse.
    Jacks T; Fazeli A; Schmitt EM; Bronson RT; Goodell MA; Weinberg RA
    Nature; 1992 Sep; 359(6393):295-300. PubMed ID: 1406933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice.
    Sumegi J; Uzvolgyi E; Klein G
    Cell Growth Differ; 1990 May; 1(5):247-50. PubMed ID: 1964797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products.
    Levine AJ; Momand J
    Biochim Biophys Acta; 1990 Jun; 1032(1):119-36. PubMed ID: 2142001
    [No Abstract]   [Full Text] [Related]  

  • 39. Prediction of homologous binding sites on RB and p107 common for viral oncoproteins and cellular ligands.
    Wendtner CM; Radulescu RT
    J Mol Recognit; 1992 Dec; 5(4):125-32. PubMed ID: 1339480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p53 tumour suppressor gene.
    Levine AJ; Momand J; Finlay CA
    Nature; 1991 Jun; 351(6326):453-6. PubMed ID: 2046748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.